Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FVWBJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,278
Award facts
- Contract value 100% obligated
- $1,278.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) valued at $1,278.16. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and related government entities. The company's contract portfolio with the DLA demonstrates extensive capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This specific delivery order for ondansetron, a commonly used antiemetic medication, reflects the routine pharmaceutical fulfillment operations under the larger global pharmaceutical support vehicle that positions AmerisourceBergen as a key strategic partner in the DLA's supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FVWBJ?
SPE2DB25FVWBJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FVWBJ worth?
The government has obligated $1,278 on SPE2DB25FVWBJ.
Is contract SPE2DB25FVWBJ an order under another contract?
Yes. SPE2DB25FVWBJ is a delivery order under SPE2DB25D3504, an indefinite delivery contract.
Was contract SPE2DB25FVWBJ competed?
The extent of competition for SPE2DB25FVWBJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award